| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| Biologic Therapy |
0 |
0.75 |
| Antigens |
0 |
0.74 |
| Acute Respiratory Distress Syndrome |
0 |
0.24 |
| Meta-Analysis |
0 |
0.23 |
| Polymerase Chain Reaction |
0 |
0.17 |
| Severe Acute Respiratory Syndrome |
0 |
0.17 |
| Pandemic |
0 |
0.11 |
| Board Certification |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Evidence-Based Medicine |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Point-of-Care |
0 |
0.06 |
| Stress |
0 |
0.06 |
| UK Site Content |
0 |
0.06 |